General Information of Drug (ID: DMQX5UA)

Drug Name
FLX-787 Drug Info
Indication
Disease Entry ICD 11 Status REF
Amyotrophic lateral sclerosis 8B60.0 Phase 2 [1]
Multiple sclerosis 8A40 Phase 2 [2]
Muscle spasm MB47.3 Phase 2 [1]
Cross-matching ID
TTD Drug ID
DMQX5UA

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Flanvotumab DM2SALJ Melanoma 2C30 Phase 1 [3]
Drug Name Drug ID Indication ICD 11 Highest Status REF
HC-030031 DMOY2AI Inflammation 1A00-CA43.1 Investigative [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Melanoma antigen gp75 (TYRP1) TTFRV98 TYRP1_HUMAN Activator [2]
Transient receptor potential channel (TRP channel) TT79AOF NOUNIPROTAC Agonist [1]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 National Cancer Institute Drug Dictionary (drug id 675217).
4 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4211).